SS Innovations International (SSII) Non-Current Deffered Revenue (2022 - 2026)

SS Innovations International's (SSII) quarterly Non-Current Deffered Revenue came in at $7.5 million in Q1 2026, up 38.78% year-on-year from $5.4 million in Q1 2025, and up 5.06% quarter-over-quarter from $7.1 million in Q4 2025.

SS Innovations International (SSII) Non-Current Deffered Revenue (2022 - 2026) Analysis & Trends

SS Innovations International has disclosed Non-Current Deffered Revenue across 5 years of filings, most recently posting $7.5 million for Q1 2026.

  • Non-Current Deffered Revenue for Q1 2026 came in at $7.5 million, up 38.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 million (up 38.78% YoY), and the FY2025 annual result was $7.1 million, up 38.0% from the prior year.
  • Non-Current Deffered Revenue came in at $7.5 million for Q1 2026 at SS Innovations International, up from $7.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $7.5 million in Q1 2026 to a low of $42141.0 in Q4 2022.
  • The 5-year median for Non-Current Deffered Revenue is $4.3 million (2024), against an average of $3.9 million.
  • Across the five-year window, Non-Current Deffered Revenue surged 2128.59% in 2023 and surged 38.0% in 2025, its largest moves.
  • SS Innovations International's Non-Current Deffered Revenue stood at $42141.0 in 2022, then soared by 2128.59% to $939150.0 in 2023, then surged by 450.92% to $5.2 million in 2024, then jumped by 38.0% to $7.1 million in 2025, then increased by 5.06% to $7.5 million in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $7.5 million (Q1 2026), $7.1 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 512.79 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 SS Innovations International 689.95 Mn 666.34 Mn 5.33 Mn 7.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.50 Mn
Dec 31, 2025 7.14 Mn
Sep 30, 2025 6.28 Mn
Jun 30, 2025 5.78 Mn
Mar 31, 2025 5.41 Mn
Dec 31, 2024 5.17 Mn
Sep 30, 2024 4.30 Mn
Jun 30, 2024 3.73 Mn
Mar 31, 2024 3.13 Mn
Dec 31, 2023 939,150.00
Sep 30, 2023 796,235.00
Jun 30, 2023 348,993.00
Dec 31, 2022 42,141.00